ストックスクリーナーアプリを入手
1.49
2.05%
0.03
前日終値:
$1.46
開ける：
$1.46
24時間の取引高:
328.74K
Relative Volume:
0.12
時価総額：
$62.40M
収益：
-
当期純損益:
$-11.24M
株価収益率:
-1.9567
EPS:
-0.7615
ネットキャッシュフロー:
$-4.79M
1週間 パフォーマンス:
+2.05%
1か月 パフォーマンス:
+4.20%
6か月 パフォーマンス:
+20.16%
1年 パフォーマンス:
+33.04%
1日の値動き範囲:
$1.4507
$1.53
1週間の範囲:
$1.41
$1.53
52週間の値動き範囲:
$0.73
$2.45
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
MIRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.49 | 61.14M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
1,027.51 | 903.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
211.58 | 505.98B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.32 | 395.86B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.57 | 253.97B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.30 | 245.75B | 63.90B | 19.05B | 13.05B | 7.5596 |
Mira Pharmaceuticals Inc (MIRA) 最新ニュース
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Daytona Beach News-Journal
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Why MIRA Pharmaceuticals Inc. stock remains on watchlistsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
MIRA Pharmaceuticals (NASDAQ:MIRA) and Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in MIRA Pharmaceuticals Inc. stockQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
Will MIRA Pharmaceuticals Inc. stock see PE expansionProfit Target & Trade Opportunity Analysis - newser.com
What high frequency data says about MIRA Pharmaceuticals Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Why MIRA Pharmaceuticals Inc. stock is favored by pension funds2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com
Is MIRA Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will MIRA Pharmaceuticals Inc. stock maintain growth storyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com
Is MIRA Pharmaceuticals Inc. showing signs of accumulationMarket Growth Report & Long-Term Capital Growth Ideas - newser.com
Will MIRA Pharmaceuticals Inc. continue its uptrendDip Buying & Smart Allocation Stock Reports - newser.com
Should you wait for a breakout in MIRA Pharmaceuticals Inc.July 2025 PreEarnings & High Accuracy Investment Entry Signals - newser.com
Will MIRA Pharmaceuticals Inc. stock benefit from sector rotation2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - newser.com
Applying big data sentiment scoring on MIRA Pharmaceuticals Inc.Earnings Miss & Long-Term Growth Stock Strategies - newser.com
What earnings revisions data tells us about MIRA Pharmaceuticals Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Using R and stats models for MIRA Pharmaceuticals Inc. forecasting2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Is MIRA Pharmaceuticals Inc. forming a bottoming baseLong Setup & Fast Entry and Exit Trade Plans - newser.com
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain - Barnstable Patriot
Mira Pharmaceuticals Inc (MIRA) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
0.19%
大文字化:
|
ボリューム (24 時間):